Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial

Emmylou Beekman, Ilse Mesters, Erik J M Hendriks, Jean W M Muris, Geertjan Wesseling, Silvia M A A Evers, Guus M Asijee, Annemieke Fastenau, Hannah N Hoffenkamp, Rik Gosselink, Onno C P van Schayck, Rob A de Bie, Emmylou Beekman, Ilse Mesters, Erik J M Hendriks, Jean W M Muris, Geertjan Wesseling, Silvia M A A Evers, Guus M Asijee, Annemieke Fastenau, Hannah N Hoffenkamp, Rik Gosselink, Onno C P van Schayck, Rob A de Bie

Abstract

Background: Physical exercise training aims at reducing disease-specific impairments and improving quality of life in patients with chronic obstructive pulmonary disease (COPD). COPD exacerbations in particular negatively impact COPD progression. Physical therapy intervention seems indicated to influence exacerbations and their consequences. However, information on the effect of physical therapy on exacerbation occurrence is scarce. This study aims to investigate the potential of a protocol-directed physical therapy programme as a means to prevent or postpone exacerbations, to shorten the duration or to decrease the severity of exacerbations in patients with COPD who have recently experienced an exacerbation. Besides, this study focuses on the effect of protocol-directed physical therapy on health status and quality of life and on cost-effectiveness and cost-utility in patients with COPD who have recently experienced an exacerbation.

Methods/design: A prospective cohort of 300 COPD patients in all GOLD stages will be constructed. Patients will receive usual multidisciplinary COPD care including guideline-directed physical therapy. Patients in this cohort who have GOLD stage 2 to 4 (post-bronchodilator FEV1/FVC < 0.7 and FEV1 < 80% of predicted), who receive reimbursement by health insurance companies for physical therapy (post-bronchodilator Tiffeneau-index < 0.6) and who experience a COPD exacerbation will be asked within 56 days to participate in a cohort-nested prospective randomised controlled trial (RCT). In this RCT, the intervention group will receive a strict physical therapy programme for patients with COPD. This protocol-directed physical therapy (pdPT) will be compared to a control group that will receive sham-treatment, meaning no or very low-intensity exercise training (ST). An economic evaluation will be embedded in the RCT. Anthropometric measurements, comorbidities, smoking, functional exercise capacity, peripheral muscle strength, physical activity level, health related quality of life, patients' perceived benefit, physical therapy compliance, motivation level, level of effective mucus clearance, exacerbation symptoms and health care contacts due to COPD will be recorded. Follow-up measurements are scheduled at 3 and 6 weeks, 3, 6, 12 and 24 months after inclusion.

Discussion: Ways to minimise potential problems regarding the execution of this study will be discussed.

Trial registration: The Netherlands National Trial Register NTR1972.

Figures

Figure 1
Figure 1
Framework of the study: a cohort-nested, prospective, randomised controlled trial. Definition of abbreviations: COPD = Chronic Obstructive Pulmonary Disease; RCT = Randomised Controlled Trial; Tiffeneau < 0.6 = Tiffeneau index (FEV1/VC) < 0.6*; FEV1 = Forced Expiratory Volume in one second*; FVC = Forced Vital Capacity*; GOLD I = mild COPD, FEV1/FVC < 0.7 and FEV1 ≥ 80% of predicted*; GOLD II = moderate COPD, FEV1/FVC < 0.7 and 50% ≤ FEV1 < 80% of predicted*; GOLD III = severe COPD, FEV1/FVC < 0.7 and 30% ≤ FEV1 < 50% of predicted*; GOLD IV = very severe COPD, FEV1/FVC < 0.7 and FEV1 < 30% of predicted or FEV1 < 50% of predicted* plus chronic respiratory failure. *All lung functions are post-bronchodilator values.
Figure 2
Figure 2
Flowchart of the RCT. Definition of abbreviations: COPD = chronic obstructive pulmonary disease; pdPT = protocol-directed physical therapy; ST = sham-treatment, including no or very low-intensity exercise training.
Figure 3
Figure 3
Planning of outcome measurements in the RCT. The diary cards are not included in the Figure, but they are used by the patient every day of every month until T6. In the cohort, the baseline measurement is followed by the same measurements as on T3 in the RCT and are repeated every three months for at least twelve consecutive months. Definition of abbreviations: T0 = baseline measurement; T1 – T10 = consecutive measurements in time after the baseline measurement; A = Anthropometric measures; B = Bicycle test results (maximal cardiopulmonary exercise test (CPET)); S = Spirometry results; 6 = 6MWT + Borg score and mGUG + Borg; M = peripheral muscle strength; P = physical activity in daily life with accelerometer; Q = CCQ*, CRQ-SR, EQ-5D*, DS14, MRC and level of effective mucus clearance, level of motivation, physical activity, physical therapy compliance*; C = questionnaire to assess direct and indirect costs; and G = Global Perceived Effect*. Measurement occasions are explained in the Table above the Figure. *The only measurements on T1 and T2.

References

    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of COPD. 2011.
    1. World Health Organization. The global burden of disease: 2004 update. 2008. .
    1. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med. 2005;99(B):S3–S10.
    1. Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches. Eur Respir J. 2005;25(6):1084–1106. doi: 10.1183/09031936.05.00139104.
    1. Spruit MA. Enhanced physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease. Chron Respir Dis. 2005;2(3):117–119. doi: 10.1191/1479972305cd083ed.
    1. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest. 2000;117(2 Suppl):5S–9S.
    1. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi: 10.7326/0003-4819-106-2-196.
    1. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax. 2003;58(9):752–756. doi: 10.1136/thorax.58.9.752.
    1. Puhan MA, Schunemann HJ, Frey M, Scharplatz M, Bachmann LM. How should COPD patients exercise during respiratory rehabilitation? comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax. 2005;60(5):367–375. doi: 10.1136/thx.2004.033274.
    1. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204–1213. discussion 1213–1205.
    1. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129(3):536–544. doi: 10.1378/chest.129.3.536.
    1. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–778. doi: 10.1136/thx.2006.060145.
    1. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J, Wouters EF. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012;13(3):291–297. doi: 10.1016/j.jamda.2011.06.009.
    1. Chavannes N, Vollenberg JJ, van Schayck CP, Wouters EF. Effects of physical activity in mild to moderate COPD: a systematic review. Br J Gen Pract. 2002;52(480):574–578.
    1. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006. 4, CD003793.
    1. Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ. 2004;329(7476):1209. doi: 10.1136/bmj.38258.662720.3A.
    1. Murphy N, Bell C, Costello RW. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir Med. 2005;99(10):1297–1302. doi: 10.1016/j.rmed.2005.02.033.
    1. Almeida P, Rodrigues F. Exercise training modalities and strategies to improve exercise performance in patients with respiratory disease. Rev Port Pneumol. 2014;20(1):36–41. doi: 10.1016/j.rppneu.2013.10.004.
    1. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(1):19–38. doi: 10.1164/rccm.200408-1109SO.
    1. Puente-Maestu L, Tena T, Trascasa C, Perez-Parra J, Godoy R, Garcia MJ, Stringer WW. Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol. 2003;88(6):580–587. doi: 10.1007/s00421-002-0743-9.
    1. Patessio A, Carone M, Ioli F, Donner CF. Ventilatory and metabolic changes as a result of exercise training in COPD patients. Chest. 1992;101(5 Suppl):274S–278S.
    1. Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med. 2009;360(13):1329–1335. doi: 10.1056/NEJMct0804632.
    1. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest. 2005;128(4):2025–2034. doi: 10.1378/chest.128.4.2025.
    1. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011. 10, CD005305.
    1. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi: 10.1016/S0140-6736(07)61382-8.
    1. Gosselink R. Respiratory rehabilitation: improvement of short- and long-term outcome. Journal. 2002;20(1):4–5. Editorial.
    1. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Estudi del Factors de Risc d’Aguditzacio de la Mi. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–105. doi: 10.1136/thorax.58.2.100.
    1. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(1):158–164. doi: 10.1164/ajrccm.159.1.9803117.
    1. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10(2):417–423. doi: 10.1183/09031936.97.10020417.
    1. Guell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, Sanchis J. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest. 2000;117(4):976–983. doi: 10.1378/chest.117.4.976.
    1. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? a 2-year controlled study. Chest. 2001;119(6):1696–1704. doi: 10.1378/chest.119.6.1696.
    1. Davidson WJ, Verity WS, Traves SL, Leigh R, Ford GT, Eves ND. Effect of incremental exercise on airway and systemic inflammation in patients with COPD. J Appl Physiol. 2012;112(12):2049–2056. doi: 10.1152/japplphysiol.01615.2011.
    1. Kirsten DK, Taube C, Lehnigk B, Jorres RA, Magnussen H. Exercise training improves recovery in patients with COPD after an acute exacerbation. Respir Med. 1998;92(10):1191–1198. doi: 10.1016/S0954-6111(98)90420-6.
    1. Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality – a systematic review. Respir Res. 2005;6:54. doi: 10.1186/1465-9921-6-54.
    1. Gosselink RA, Langer D, Burtin C, Probst VS, Hendriks HJM, van der Schans CP, Paterson WJ, Verhoef-van Wijk MCE, Straver RV, Klaassen M, Troosters T, Decramer M, Ninane V, Delguste P, Muris J, Wempe J. KNGF-guideline for physical therapy in chronic obstructive pulmonary disease. Royal Dutch Society for Physical Therapy. 2008;118(4):1–60.
    1. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi: 10.1164/ajrccm.161.5.9908022.
    1. Decramer M, Nici L, Nardini S, Reardon J, Rochester CL, Sanguinetti CM, Troosters T. Targeting the COPD exacerbation. Respir Med. 2008;102(Suppl 1):S3–S15.
    1. Kosmas EN, Vey V, Fraggou M, Papaneofytou I, Athanassa Z, Koutsoukou A, Vogiatzis I, Georgiadou O, Koulouris N, Orfanidou D, Roussos C. Effects of pulmonary rehabilitation on exacerbation rate, hospitalizations, length of hospital stay and public health economics in patients with moderate-to-severe chronic obstructive pulmonary disease. Chest. 2005;128(4_MeetingAbstracts):254S.
    1. Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in Observational Epidemiology. 2. New York: Oxford University Press; 1996.
    1. Decision Support Systems LP. Researcher’s toolkit, sample size calculator (Percentages, two samples) .
    1. Smeele IJM, Van Weel C, Van Schayck CP, Van der Molen T, Thoonen B, Schermer T, Sachs APE, Muris JWM, Chavannes NH, Kolnaar BGM, Grol MH, Geijer RMM. The Dutch college of general practitioners (NHG) practice guideline COPD [NHG-standaard COPD] Huisarts Wet. 2007;50(8):362–379.
    1. Gosselink R, Decramer M. Rehabilitation in Chronic Obstructive Pulmonary Disease [Revalidatie bij chronische obstructieve longziekten] Elsevier Gezondheidszorg: Maarssen; 2001.
    1. Ministry of Health, Welfare and Sport. Youth monitor, definitions - Dutch healthy exercise norm: NNGB (Nederlandse Norm Gezond Bewegen) 2008. .
    1. Van der Leeden M, Staal JB, Beekman E, Hendriks H, Mesters I, de Rooij M, de Vries N, Werkman M, de Graaf-Peters V, de Bie R, Hulzebos E, Nijhuis-van der Sanden R, Dekker J. Development of a framework to describe goals and content of exercise interventions in physical therapy: a mixed method approach including a systematic review. Phys Ther Rev. 2014;19(1):1–14. doi: 10.1179/1743288X13Y.0000000095.
    1. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s.
    1. Caramori G, Adcock IM, Papi A. Clinical definition of COPD exacerbations and classification of their severity. South Med J. 2009;102(3):277–282. doi: 10.1097/SMJ.0b013e3181836b73.
    1. Walters EH, Walters J, Wills KE, Robinson A, Wood-Baker R. Clinical diaries in COPD: compliance and utility in predicting acute exacerbations. Int J Chron Obstruct Pulmon Dis. 2012;7:427–435.
    1. Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax. 2009;64(11):956–962. doi: 10.1136/thx.2008.112243.
    1. Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J. 2003;22(6):931–936. doi: 10.1183/09031936.03.00038303.
    1. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005;86(10):1979–1985. doi: 10.1016/j.apmr.2005.04.016.
    1. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996;76(3):248–259.
    1. AmericanThoracicSociety. Committee on proficiency standards for clinical pulmonary function laboratories, ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
    1. Hill K, Wickerson LM, Woon LJ, Abady AH, Overend TJ, Goldstein RS, Brooks D. The 6-min walk test: responses in healthy Canadians aged 45 to 85 years. Appl Physiol Nutr Metab. 2011;36(5):643–649. doi: 10.1139/h11-075.
    1. van der Leeden M, van der Esch M. Optimal physiotherapeutic interventions [Optimale fysiotherapeutische interventies] FysioPraxis. 2010;19(9):26–29.
    1. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010;7(3):214–228. doi: 10.3109/15412555.2010.481697.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe